⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1805336 | 0.85 | PTGS1 (0.45) | — | |
| SCHEMBL17266136 | 0.84 | APP (0.44) | — | |
| SCHEMBL30026428 | 0.82 | PTGS1 (0.43) | — | |
| SCHEMBL186081 | 0.81 | LMNA (0.38) | — | |
| SCHEMBL27863879 | 0.79 | LMNA (0.36) | — | |
| SCHEMBL19705810 | 0.79 | LMNA (0.36) | — | |
| SCHEMBL29979535 | 0.79 | CYP2D6 (0.37) | — | |
| SCHEMBL2692559 | 0.79 | LMNA (0.36) | — | |
| SCHEMBL8513206 | 0.78 | APP (0.42) | — | |
| SCHEMBL1938285 | 0.77 | APEX1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621458-B1 | ANTIMICROBIAL DENTAL CARE PREPARATION | GEISTLICH PHARMA AG (CH) | 2017-04-19 | — | — | EP | claimed |
| WO-2011107283-A2 | FORMULATIONS OF TAUROLIDINE AND METHOD FOR THE PRODUCTION THEREOF | GAMPTEC GMBH (DE) | 2011-09-09 | — | — | WO | claimed |
| US-20230159477-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | GEISTLICH PHARMA AG (CH) | 2023-05-25 | — | — | US | disclosed |
| US-10968190-B2 | Processes for preparing oxathiazin-like compounds | GEISTLICH PHARMA AG (CH) | 2021-04-06 | — | — | US | disclosed |
| US-9844555-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2017-12-19 | — | — | US | disclosed |
| US-9844555-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2017-12-19 | — | — | US | disclosed |
| US-20170275248-A1 | Carbondisulfide Derived Zwitterions | TPAT IP LLC | 2017-09-28 | — | — | US | disclosed |
| US-20170196876-A1 | OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2017-07-13 | — | — | US | disclosed |
| US-9676709-B2 | Carbondisulfide derived zwitterions | TPAT IP LLC | 2017-06-13 | — | — | US | disclosed |
| US-20170129853-A1 | Carbondisulfide Derived Zwitterions | TPAT IP LLC | 2017-05-11 | — | — | US | disclosed |
| EP-2621458-B1 | ANTIMICROBIAL DENTAL CARE PREPARATION | GEISTLICH PHARMA AG (CH) | 2017-04-19 | — | — | EP | disclosed |
| WO-2001039763-A2 | USE OF METHYLOL-CONTAINING COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF TUMORS | RHODE ISLAND HOSPITAL, A LIFESPAN PARTNER (US) | 2001-06-07 | — | — | WO | disclosed |
| EP-1102789-A1 | MONOCYCLIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTION AND COMPOSITIONS CONTAINING THEM | Menarini Ricerche S.p.A. (IT) | 2001-05-30 | — | — | EP | disclosed |
| EP-1066830-A2 | Uses and compositions for treating primary and secondary tumors of the central nervous system (cns) | ED. GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 2001-01-10 | — | — | EP | disclosed |
| WO-2000008046-A1 | MONOCYCLIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTION AND COMPOSITIONS CONTAINING THEM | MENARINI RICERCHE S.P.A. (IT) | 2000-02-17 | — | — | WO | disclosed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | disclosed |
| US-4543216-A | REACTING A VINYL BENZYL HALIDE WITH AN AMINO ACID OR AMINO SULFONIC ACID | NIPPON PAINT CO., LTD. (JP) | 1985-09-24 | — | — | US | disclosed |
| US-4452746-A | TO MODIFY PROPERTIES OF HIGH MOLECULAR WEIGHT COMPOUNDS | NIPPON PAINT CO., LTD. (JP) | 1984-06-05 | — | — | US | disclosed |
| US-4171225-A | HYDROXYMETHYL AMINO ALKYLCARBOXYLIC OR -SULFONIC ACID ALKALI SALTS AS STABLE REDUCING AGENTS | U.S. PHILIPS CORPORATION (US) | 1979-10-16 | — | — | US | disclosed |